Clinical Impact of Recurrence Beyond the Milan Criteria After Curative Resection of Hepatocellular, Takeshi Terashima, Hana Sanada, Noboru Takata, Tomoyuki Hayashi, Akihiro Seki, Hidetoshi Nakagawa Tadashi Toyama Shinichi Nakanuma, Isamu Makino, Kazuo Yasumoto, Shintaro Yagi, Taro Yamashita,, 00:1-11, 2025
Efficacy and safety of FOLFOX for Japanese patients with advanced biliary tract cancer as second-line or later chemotherapy (JON2107-Bstudy)., Terashima, Takeshi; Morizane, Chigusa; Chida, Akihiko; Todaka, Akiko; Umemoto, Kumiko; Kawakami, Yujiro; Yamashita, Tatsuya; Ueno, Makoto; Furuse, Junji; Nagano,, International Journal of Clinical Oncology, : , 2025
The efficacy and safety of adding hepatic arterial infusion chemotherapy using cisplatin to lenvatinib for advanced hepatocellular carcinoma., Terashima T, Yamamoto M, Toyama T, Kido H, Takata N, Hayashi T, Seki A, Nakagawa H, Nio K, Iida N, Yamada S, Shimakami T, Takatori H, Mizukoshi E, Honda M, Yamashita T, Hepatology Research, 55(7):1026-1037, Apr. 2025
